Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Tofacitinib may help treat hair loss in children with alopecia areata.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Etanercept may not prevent alopecia areata from coming back.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Upadacitinib improved multiple immune-related conditions in one patient.

Keeping human skin stem cells is easier with low temperatures and mTOR inhibition.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

The new skin patch with human matrix and antibiotic improves wound healing.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.